We are live on !
Find out more
Jim Simons Renaissance Technologies
AUM
$72.6B
Turnover
31.08%
1-Year Est. Return
54.88%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Fund
S&P 500
This Quarter Est. Return
+4.17%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$42.9B
AUM Growth
+$1.2B
(+2.9%)
Cap. Flow
-$23.9M
Cap. Flow % of AUM
Cap. Flow %
-0.06%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
3,246
New
450
Increased
1,272
Reduced
1,008
Closed
492
Avg Time Held
0.7
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Industrials | 10.6% |
| 5 | Consumer Staples | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
McDonald's
MCD
$175B
| $836M | 1.95% |
8,293,900
-227,487
| -3% | -$23M |
2013 Q2
4 quarters
|
|
2
Novo Nordisk
NVO
$173B
| $783M | 1.83% |
33,906,000
+1,746,400
| +5% | +$38.6M |
2013 Q2
4 quarters
|
|
|
3
Colgate-Palmolive
CL
$74.6B
| $655M | 1.53% |
9,605,500
+2,259,100
| +31% | +$151M |
2013 Q2
4 quarters
|
|
4
TSMC
TSM
$2.23T
| $564M | 1.31% |
26,354,151
+1,064,600
| +4% | +$21.9M |
2013 Q2
4 quarters
|
|
|
LLTC
5
DELISTED
Linear Technology Corp
LLTC
| $552M | 1.29% |
11,732,400
+436,900
| +4% | +$20.2M |
2013 Q2
4 quarters
|
|
6
Hershey
HSY
$33.8B
| $547M | 1.27% |
5,615,500
+1,116,826
| +25% | +$110M |
2013 Q2
4 quarters
|
|
7
Intel
INTC
$490B
| $535M | 1.25% |
17,329,900
+3,322,200
| +24% | +$91M |
2013 Q2
4 quarters
|
|
8
Apple
AAPL
$5.02T
| $518M | 1.21% |
22,293,732
-704,404
| -3% | -$15M |
2014 Q1
1 quarter
|
|
9
GSK
GSK
$100B
| $474M | 1.11% |
7,095,520
+1,487,680
| +27% | +$101M |
2013 Q2
4 quarters
|
|
10
Alaska Air
ALK
$3.93B
| $442M | 1.03% |
9,310,000
-68,602
| -0.7% | -$3.27M |
2013 Q2
4 quarters
|
|
|
TWTC
11
DELISTED
TW TELECOM INC CL A COM
TWTC
| $371M | 0.86% |
9,196,800
+260,700
| +3% | +$8.6M |
2013 Q2
4 quarters
|
|
12
Johnson & Johnson
JNJ
$617B
| $329M | 0.77% |
3,145,500
+486,300
| +18% | +$49.2M |
2013 Q2
4 quarters
|
|
|
13
IBM
IBM
$231B
| $299M | 0.7% |
1,725,691
+1,513,447
| +713% | +$272M |
2013 Q2
4 quarters
|
|
|
14
Pfizer
PFE
$170B
| $286M | 0.67% |
10,171,038
+9,692,268
| +2,024% | +$276M |
2013 Q4
2 quarters
|
|
15
Domino's
DPZ
$10.3B
| $270M | 0.63% |
3,693,800
+461,200
| +14% | +$33.8M |
2013 Q2
4 quarters
|
|
16
United Parcel Service
UPS
$84.9B
| $255M | 0.59% |
2,485,400
+722,862
| +41% | +$72.6M |
2013 Q2
4 quarters
|
|
17
TJX Companies
TJX
$161B
| $231M | 0.54% |
8,676,400
+1,595,000
| +23% | +$45.5M |
2013 Q2
4 quarters
|
|
18
NetEase
NTES
$78.9B
| $226M | 0.53% |
14,410,500
-444,000
| -3% | -$6.34M |
2013 Q2
4 quarters
|
|
19
VeriSign
VRSN
$27.9B
| $224M | 0.52% |
4,581,076
-68,824
| -1% | -$3.43M |
2013 Q2
4 quarters
|
|
20
Qualcomm
QCOM
$190B
| $221M | 0.52% |
2,796,300
-129,100
| -4% | -$10.3M |
2013 Q2
4 quarters
|
|
21
Home Depot
HD
$314B
| $216M | 0.5% |
2,667,400
-1,245,900
| -32% | -$98.3M |
2013 Q2
4 quarters
|
|
22
Mastercard
MA
$546B
| $216M | 0.5% |
2,934,300
+1,143,900
| +64% | +$85M |
2013 Q2
4 quarters
|
|
|
23
Eli Lilly
LLY
$1.13T
| $208M | 0.48% |
3,342,000
-1,914,105
| -36% | -$114M |
2013 Q2
4 quarters
|
|
24
Philip Morris
PM
$307B
| $190M | 0.44% |
2,256,600
-808,893
| -26% | -$69.6M |
2013 Q2
4 quarters
|
|
25
Becton Dickinson
BDX
$53.1B
| $183M | 0.43% |
1,589,468
+213,918
| +16% | +$24.3M |
2013 Q3
3 quarters
|
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,272 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.